title: Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.
authors.forename: Jason W
authors.initials: JW
authors.lastname: Bennett
authors.forename: Brandon S
authors.initials: BS
authors.lastname: Pybus
authors.forename: Anjali
authors.initials: A
authors.lastname: Yadava
authors.forename: Donna
authors.initials: D
authors.lastname: Tosh
authors.forename: Jason C
authors.initials: JC
authors.lastname: Sousa
authors.forename: William F
authors.initials: WF
authors.lastname: McCarthy
authors.forename: Gregory
authors.initials: G
authors.lastname: Deye
authors.forename: Victor
authors.initials: V
authors.lastname: Melendez
authors.forename: Christian F
authors.initials: CF
authors.lastname: Ockenhouse
mesh_terms: D000293:Adolescent; D000328:Adult; D019389:Cytochrome P-450 CYP2D6 / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D005260:Female; D006801:Humans; D016780:Malaria, Vivax / Q000188:drug therapy*; D008297:Male; D008661:Metabolism, Inborn Errors; D008875:Middle Aged; D018512:Parasitemia / Q000188:drug therapy; D010641:Phenotype; D010966:Plasmodium vivax / Q000187:drug effects; D011319:Primaquine / Q000378:metabolism / Q000627:therapeutic use*; D012008:Recurrence; D017211:Treatment Failure; D055815:Young Adult
chemical_list: D019389:Cytochrome P-450 CYP2D6; D011319:Primaquine